Immune and cell modulation by amino acids

Clinical Nutrition

Volumn 26, Issue 5, 2007, Pages 535-544

  Roth, Erich ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Glutamine; Immuno nutrition; Protein catabolism

Indexed keywords

AMINO ACID; ARGININE; CORTICOSTEROID; CYSTEINE; CYSTINE; DIPEPTIDE; GLUTAMINE; GLUTATHIONE; GLYCINE; HEAT SHOCK FACTOR 1; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEUCINE; MESSENGER RNA; NEUROMUSCULAR BLOCKING AGENT; TAURINE; TRANSFER RNA; TRYPTOPHAN; UNCLASSIFIED DRUG;

AGGRESSION; AGING; AMINO ACID DEFICIENCY; APOPTOSIS; ARTICLE; BED REST; CELL SIZE; CRITICAL ILLNESS; DIET THERAPY; DRUG MECHANISM; DRUG MEGADOSE; ENZYME ACTIVATION; EVIDENCE BASED MEDICINE; GLUTAMINE DEFICIENCY; GLUTATHIONE METABOLISM; HALF LIFE TIME; HUMAN; IMMOBILIZATION; IMMUNE RESPONSE; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE FUNCTION; METABOLIC DISORDER; MONOCYTE; MULTIPLE TRAUMA; MUSCLE ATROPHY; MYOPATHY; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PROTEIN DEGRADATION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; SEPSIS; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; WOUND; WOUND HEALING;

AGING; CELL PHYSIOLOGY; CRITICAL ILLNESS; GLUTAMINE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNITY, CELLULAR; MUSCULAR ATROPHY; OXIDATIVE STRESS;

EID: 35448986540     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.05.007     Document Type: Article

References (62)

1. Cuthbertson D.P. The distribution of nitrogen and sulphur in the urine during conditions of increased catabolism. Biochem J 25 (1931) 236-246
2. Cuthbertson D.P. Observation on the disturbances of metabolism produced by injury to the limbs. Q J Med 1 (1932) 232-249
3. Cuthbertson D.P. Post-shock metabolic response. Lancet i (1942) 433-437
4. Carmeli E., Celeman R., and Reznick A.Z. The biochemistry of aging muscle. Exp Gerontol 37 (2002) 477-489
5. Doherty T.J. Aging and sarcopenia. J Appl Physiol 95 (2003) 1717-1727
6. Kadi F., Charrifi N., Denis C., and Lexell J. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve 29 (2004) 120-127
7. Roubenoff R. Catabolism of aging: is it an inflammatory process?. Curr Opin Clin Nutr Metab Care 6 (2003) 295-299
8. Giresi P.G., Stevenson E.J., Theilhaber J., et al. Identification of a molecular signature of sarcopenia. Physiol Genomics 21 (2005) 253-263
9. Degens H., and Alway S.E. Control of muscle size during disuse, disease, and aging. Int J Sport Med 27 (2006) 94-99
10. Jackman R.W., and Kabdarian S.C. The molecular basis of skeletal muscle atrophy. Am J Physiol Cell Physiol 287 (2004) C834-C843
11. Reardon K.A., Davis J., Kapsa R., Choong P., and Byrne E. Myostatin, insulin-like growth factor-1, and leukaemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve 24 (2001) 893-899
12. Stevenson E.J., Giresi P.G., Koncarevic A., and Kandarian S.C. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 551 1 (2003) 38-48
13. Biolo G., Ciocchi B., Lebenstedt M., et al. Short-term bed rest impairs amino acid-induced protein anabolism in humans. J Physiol 558 2 (2004) 381-388
14. Hund E. Myopathy in critically ill patients. Crit Care Med 27 (1999) 2544-2547
15. Minnaard R., Drost M.R., Wagenmakers A.J.M., van Kranenburg G.P., Kuipers H., and Hesselink M.K.C. Skeletal muscle wasting and contractile performance in septic rats. Muscle Nerve 31 (2005) 339-348
16. Duan X, Berthiaume F, Yarmush D, Yarmush ML. Proteomic analysis of altered protein expression in skeletal muscle of rats in hypermetabolic state induced by burn injury. Biochem J 2006, electronic publication.
17. Lehr U. Psychologie des Alterns (1972), Quelle & Meyer, Wiesbaden
18. Roth E., Funovics J., Mühlbacher F., et al. Metabolic disorders in severe abdominal sepsis: glutamine deficiency in skeletal muscle. Clin Nutr 1 (1982) 25-41
19. Newsholme P., Curi R., and Gordon S. Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J 239 (1986) 121-125
20. Spittler A., Winkler S., Götzinger P., et al. Influence of glutamine on the phenotype and function of human monocytes. Blood 86 (1995) 1564-1569
21. Exner R., Weingartmann G., Eliasen M.M., et al. Glutamine deficiency renders human monocytic cells more susceptible to specific apoptosis triggers. Surgery 131 (2002) 75-80
22. Weingartmann G., Oehler R., Derkits S., Oismuller C., Fuegger R., and Roth E. HSP70 expression in granulocytes and lymphocytes of patients with polytrauma: comparison with plasma glutamine. Clin Nutr 18 (1999) 121-124
23. Oehler R., Pusch E., Zellner M., et al. Cell type specific variations in the induction of Hsp70 in human leukocytes by fever-like whole body hyperthermia. Cell Stress Chaperones 6 (2001) 306-315
24. Oehler R., Pusch E., Dungel P., Zellner M., Eliasen M.M., Brabec M., et al. Reduced expression of the major inducible 70 kDa heat shock protein in glutamine starved leukocytes. Br J Nutr 87 (2002) S17-S21
25. Pollheimer J., Zellner M., Eliasen M.M., et al. Increased susceptibility of glutamine-depleted monocytes to fever-range hyperthermia. The role of 70-kDa heat shock protein. Ann Surg 241 (2005) 349-355
26. Häussinger D., Roth E., Lang F., et al. Cellular hydration state: an important determinant of protein catabolism in health and disease. Lancet 341 (1993) 1330-1332
27. Exner R., Wessner B., Manhart N., and Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr 112 (2000) 610-616
28. Roth E., Oehler R., Manhart N., et al. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 18 (2002) 217-221
29. Manhart N., Vierlinger K., Habel O., et al. Lipopolysaccharide causes atrophy of Peyer's patches and an increased expression of CD28 and B7 costimulatory ligands. Shock 14 (2000) 478-483
30. Manhart N., Vierlinger K., Spittler A., et al. Oral feeding with glutamine prevents lymphocyte and glutathione depletion of Peyer's patches in endotoxemic mice. Ann Surg 234 (2001) 92-97
31. Manhart N., Vierlinger K., Akomeah R., Bergmeister H., Spittler A., and Roth E. Influence of enteral diets supplemented with key nutrients on lymphocyte subpopulations in Peyer's patches of endotoxin-boostered mice. Clin Nutr 19 (2000) 265-269
32. Wessner B., Strasser E.M., Spittler A., and Roth E. Effect of single and combined supply of glutamine, glycine, N-actylcysteine, and R,S-α-lipoic acid on glutathione content of myelomonocytic cells. Clin Nutr 22 (2003) 515-522
33. Ko Y.G., Kim E.Y., Kim T., et al. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 276 (2001) 6030-6036
34. Hardie D.G., and Hawley S.A. AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23 (2001) 1112-1119
35. Inoki K., and Guan K.L. Complexity of the TOR signaling network. Trends Cell Biol 16 (2006) 206-212
36. Eliasen M.M., Winkler W., Jordan V., et al. Adaptive cellular mechanisms in response to glutamine-starvation. Front Biosci 11 (2006) 3199-3211
37. Eliasen M.M., Brabec M., Gerner C., et al. Reduced stress tolerance of glutamine-deprived human monocytic cells is associated with selective down-regulation of Hsp70 by decreased mRNA stability. J Mol Med 84 (2006) 147-158
38. Oudemans-van Straaten H.M., Bosman R.J., Treskes M., van der Spoel H.J., and Zandstra D.F. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med 27 (2001) 84-90
39. Hiesmayr M.J., Spittler A., Lassnigg A., et al. Alterations in the number of circulating leucocytes, phenotype of monocyte and cytokine production in patients undergoing cardiothoracic surgery. Clin Exp Immunol 115 (1999) 315-323
40. Ploder M., Pelinka L., Schmuckenschlager C., et al. Lipopolysaccharide-induced tumor necrosis factor α production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients. Shock 25 (2006) 1-7
41. Exner R., Tamandl D., Goetzinger P., et al. Perioperative Gly-Gln infusion diminishes the surgery induced period of immunosuppression: accelerated restoration of the LPS stimulated TNF-alpha response. Ann Surg 237 (2003) 110-115
42. Chowienczyk P., and Ritter J. Arginine: NO more than a simple aminoacid?. Lancet 350 (1997) 901-902
43. Wu G., and Meininger C.J. Regulation of nitric oxide synthesis by dietary factors. Annu Rev Nutr 22 (2002) 61-86
44. Längle F., Roth E., Steininger R., Winkler S., and Mühlbacher F. Arginase release following liver reperfusion. Transplantation 59 11 (1995) 1542-1549
45. Längle F., Steininger R., Waldmann E., et al. Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of l-arginine during the early reperfusion period in pig liver transplantation. Transplantation 63 9 (1997) 1225-1233
46. Roth E. The impact of l-arginine-nitric oxide metabolism on ischemia/reperfusion injury. Curr Opin Clin Nutr Metab Care 1 (1998) 97-99
47. Huk I., Nanobashvili J., Neumayer C., et al. l-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96 2 (1997) 667-675
48. Efron D.T., and Barbul A. Modulation of inflammation and immunity by arginine supplements. Curr Opin Clin Nutr Metab Care 1 (1998) 531-538
49. Luiking Y.C., Poeze M., Dejong C.H., Ramsay G., and Deutz N.E. Sepsis: an arginine deficiency state?. Crit Care Med 32 10 (2004) 2135-2145
50. Hall J.C. Glycine. J Par Ent Nutr 22 (1998) 393-398
51. Zhong Z., Jones S., and Thurman R.G. Glycine minimizes reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol 270 (1996) G332-G338
52. Spittler A., Reissner C.M., Oehler R., et al. Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-α production and accelerated IL-10 expression. FASEB 13 (1999) 563-571
53. Rennie M.J., Bohé J., Smith K., Wackerhage H., and Greenhaff P. Branched-chain amino acids as fuels and anabolic signals in human muscle. J Nutr 136 (2006) 264S-268S
54. Lynch C.J., Patson B.J., Anthony J., Vaval A., Jefferson L.S., and Vary T.C. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. Am J Physiol Endocrinol Metab 283 (2002) E503-E513
55. Bohe J., Low A., Wolfe R.R., and Rennie M.J. Human muscle protein synthesis is modulated by extracellular, not intramuscular amino acid availability: a dose-response study. J Physiol 552 1 (2003) 315-324
56. Cuthbertson D., Smith K., Babraj J., et al. Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle. FASEB J 19 3 (2005) 424
57. Dröge W. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37 (2002) 1331-1343
58. Sido B., Braunstein J., Breitkreuz R., Herfarth C., and Meuer S.C. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med 192 6 (2000) 907-912
59. Grimble R.F. The effects of sulfur amino acid intake on immune function in humans. J Nutr 136 6 (2006) 1660S-1665S
60. Bouckenooghe T., Remacle C., and Reusens B. Is taurine a functional nutrient?. Curr Opin Clin Nutr Metab Care 9 6 (2006) 728-733
61. Munn D.H., Zhou M., Attwood J.T., et al. Prevention of allogenic fetal rejection by tryptophan catabolism. Science 281 5380 (1998) 1191-1193
62. Terness P., Chuang J.J., and Opelz G. The immunoregulatory role of IDO-producing human dendritic cells revisited. Trends Immunol 27 2 (2006) 68-73